Topical Naringenin for Hair Regrowth - Quick Reference Sheet
evipedia.ai
← Back

Topical Naringenin for Hair Regrowth

Created on 09/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Naringenin, a natural citrus compound applied to the scalp as a home- or pharmacy-mixed liquid, is being explored as a low-cost, non-hormonal option to support hair regrowth. Evidence comes only from laboratory work on human scalp cells and a few animal studies; no study has measured hair regrowth in people. Known risks are mild, mainly scalp irritation from the dissolving liquids. It remains an unproven, low-risk, experimental option. (Full Review)

Protocol

Tested regimen
0.5% once daily
Dissolved in ethanol, 21 days in mice; no human protocol has been tested
Human translation (untested)
About 1 mL of 0.5% (5 mg)
Once daily to dry thinning scalp; an extrapolation, not a validated dose
Time of day
Evening, dry scalp
Several hours of contact before washing; no time-of-day data exist
Time to effect
Visible change
3–6 months
Timeline of established topicals; human hair cycles are far slower than in mice
Minimum fair trial
6 months
Discontinuation after 6 months without visible benefit
Regrowth in mice
Within 21 days
Animal data only

Benefits

Contraindications
  • Pregnant or breastfeeding women (no safety data)
  • Positive patch test to propylene glycol or to citrus flavonoids
  • Active scalp dermatitis, psoriasis flares, or open wounds, or within 48 hours of microneedling
  • Children and adolescents under 18 years (no data)
  • Sudden or patchy hair loss not yet diagnosed
    •
Key Interactions
  • Prescription CYP3A4 substrates (felodipine, cyclosporine, tacrolimus, simvastatin): Monitor; relevant if oral naringenin or grapefruit extracts are added
  • Topical minoxidil: Caution; combined vehicles add scalp irritation
  • Topical retinoids (vitamin A–derived skin drugs such as tretinoin): Caution; added irritation and dermatitis risk
  • Over-the-counter ketoconazole shampoo and salicylic acid scalp products: Monitor; added irritation
  • Oral naringenin, naringin, or grapefruit-extract supplements: Caution; added CYP3A4 inhibition
  • Additive topical botanicals (rosemary oil, caffeine solutions, green tea extract): Monitor; stacked solvents increase irritation
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Scalp contact dermatitis from the solvent vehicle; systemic adverse effects after absorption
    •
  • Speculative: Drug interactions through CYP3A4 inhibition; reduced follicle blood-vessel growth; estrogen-pathway disruption
    •

Monitoring

Marker Target Why
Ferritin 70–150 ng/mL Iron reserve for follicles
TSH 0.5–2.5 mIU/L Thyroid-driven shedding
25-hydroxyvitamin D 40–60 ng/mL Deficiency linked to shedding
Zinc (serum) 90–120 µg/dL Deficiency causes shedding
Hair density (trichoscopy) No established target; change from individual baseline Objective regrowth measure
ALT and AST Below 25 U/L each Liver safety if oral use added

Cadence: Baseline photographs, hair count, blood tests, and 48–72-hour patch test; photographs and hair counts at 3 and 6 months, then every 6–12 months; blood tests at 3 months only if baseline values were abnormal; liver enzymes only with oral naringenin

Qualitative Assessment

  • Shedding: daily hair fall during washing or brushing, and pull-test counts (hairs released by a gentle tug)
  • Scalp comfort: itching, redness, scaling, or burning after application
  • Hair quality: strand thickness, texture, and visible coverage in photographs
  • Styling and confidence: perceived fullness and ease of styling
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.